Background: Deep brain stimulation (DBS) of the anterior nucleus of the thalamus) (ANT) has been suggested as a treatment option in refractory epilepsy. The targeting of ANT is especially challenging due to its poor visualization in commonly used MRI sequences, lack of easily observable symptom relief during surgery and high degree of anatomical variation between individuals. Objectives: To study whether intraoperative microelectrode recording (MER), a method widely used in movement disorder surgery, provides clinically relevant information during the ANT-DBS implantation procedure. Methods: A total of 186 MER samples from 5 patients and 10 thalami obtained from ANT-DBS surgery for refractory epilepsy were analyzed with respect to the signal characteristics and location in 3-tesla (3T) MRI STIR (short T1 inversion recovery) images. The location of each MER sample was calculated relative to visible borders of the ANT after correction of the sample locations according to the position of the final DBS electrode in postoperative CT-MRI fusion images. Results: We found that the lateral aspect of the ANT lacked spiking activity consistent with the presence of white matter. The spike frequency in samples correlating with location at the ANT showed significantly lower spike frequency compared to samples correlating with location at the ventral anterior nucleus (median 3.0 and 7.0 spikes/2 s; p < 0.05), but spike bursts were morphologically similar in appearance. Trajectories entering the dorsomedial nucleus according to 3T MRI STIR images showed a yet different firing pattern with more low-amplitude regular activity. Conclusions: Our data suggest that MER provides clinically relevant information during implantation surgery by demonstrating both nucleus-specific neuronal firing patterns and white matter laminae between different nuclear groups.

Keywords:
Microelectrode recording, Anterior nucleus of thalamus, Epilepsy, Deep brain stimulation
1.
Jones EG: The Thalamus. Cambridge, Cambridge University Press, 2007.
2.
Fisher R, et al: Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010;51:899-908.
3.
Kerrigan JF, et al: Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia 2004;45:346-354.
4.
Hodaie M, Wennberg RA, Dostrovsky JO, Lozano AM: Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia 2002;43:603-608.
5.
Lee KJ, Shon YM, Cho CB: Long-term outcome of anterior thalamic nucleus stimulation for intractable epilepsy. Stereotact Funct Neurosurg 2012;90:379-385.
6.
Lim S-N, et al: Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long-term follow-up study. Epilepsia 2007;48:342-347.
7.
Osorio I, Overman J, Giftakis J, Wilkinson SB: High-frequency thalamic stimulation for inoperable mesial temporal epilepsy. Epilepsia 2007;48:1561-1571.
8.
Yamada K, et al: MR imaging of ventral thalamic nuclei. AJNR Am J Neuroradiol 2010;31:732-735.
9.
Buentjen L, et al: Direct targeting of the thalamic anteroventral nucleus for deep brain stimulation by T1-weighted magnetic resonance imaging at 3 T. Stereotact Funct Neurosurg 2013;92:25-30.
10.
Van Buren JM, Borke RC: The mesial temporal substratum of memory. Anatomical studies in three individuals. Brain 1972;95:599-632.
11.
Möttönen T, et al: Defining the anterior nucleus of the thalamus (ANT) as a deep brain stimulation target in refractory epilepsy: delineation using 3T MRI and intraoperative microelectrode recording. Neuroimage Clin 2015;7:823-829.
12.
Child ND, Benarroch EE: Anterior nucleus of the thalamus: functional organization and clinical implications. Neurology 2013;81:1869-1876.
13.
Hodaie M, Cordella R, Lozano AM, Wennberg R, Dostrovsky JO: Bursting activity of neurons in the human anterior thalamic nucleus. Brain Res 2006;1115:1-8.
14.
Mai JK, Paxinos G, Voss T: Atlas of the Human Brain. San Diego, Academic Press, 2007.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.